Jefferies Financial Group Inc. Vertex Pharmaceuticals Inc Call Options Transaction History

Jefferies Financial Group Inc.

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2023 Feb 13, 2024	BUY	$343.0 - $410.68 $1.17 Million - $1.4 Million	3,400 Added 37.78%	12,400 $5.05 Million
Q3 2023 Nov 14, 2023	SELL	$338.18 - $362.46 $371,998 - $398,706	-1,100 Reduced 10.89%	9,000 $3.13 Million
Q2 2023 Aug 14, 2023	BUY	$314.42 - $351.91 $3.18 Million - $3.55 Million	10,100 New	10,100 $3.55 Million
Q4 2022 Sep 21, 2023	SELL	$285.76 - $321.48 $1.4 Million - $1.58 Million	-4,900 Reduced 48.51%	5,200 $1.5 Million
Q4 2022 Feb 14, 2023	BUY	$285.76 - $321.48 $1.49 Million - $1.67 Million	5,200 New	5,200 $1.5 Million

1,724

222M

1.58M

1.36M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $119B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Jefferies Financial Group Inc., based on Form 13F filings with the SEC.

Stay updated on Jefferies Financial Group Inc. with notifications on news.